| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 5 | US FAERS | |
| 2 | Ezetimibe, Simvastatin Drug Combination | FAERS: 2 | US FAERS | |
| 3 | Simvastatin | FAERS: 2 | US FAERS | |
| 4 | Cefoxitin | FAERS: 1 | US FAERS | |
| 5 | Citalopram | FAERS: 1 | US FAERS | |
| 6 | Ibandronic Acid | FAERS: 1 | US FAERS | |
| 7 | Teriparatide | FAERS: 1 | US FAERS | |
| 8 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 9 | ziprasidone | FAERS: 1 | US FAERS | |
| 10 | Bortezomib | OFFSIDES | ||
| 11 | Loperamide | OFFSIDES | ||
| 12 | Sodium Bicarbonate | OFFSIDES | ||
| 13 | Thymidine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.